1. Home
  2. CMT vs SGMT Comparison

CMT vs SGMT Comparison

Compare CMT & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMT
  • SGMT
  • Stock Information
  • Founded
  • CMT 1996
  • SGMT 2006
  • Country
  • CMT United States
  • SGMT United States
  • Employees
  • CMT N/A
  • SGMT N/A
  • Industry
  • CMT Electronic Components
  • SGMT
  • Sector
  • CMT Consumer Discretionary
  • SGMT
  • Exchange
  • CMT Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • CMT 156.7M
  • SGMT 165.4M
  • IPO Year
  • CMT N/A
  • SGMT 2023
  • Fundamental
  • Price
  • CMT $13.26
  • SGMT $4.12
  • Analyst Decision
  • CMT Strong Buy
  • SGMT Strong Buy
  • Analyst Count
  • CMT 1
  • SGMT 7
  • Target Price
  • CMT $27.00
  • SGMT $25.71
  • AVG Volume (30 Days)
  • CMT 35.3K
  • SGMT 877.5K
  • Earning Date
  • CMT 03-11-2025
  • SGMT 03-24-2025
  • Dividend Yield
  • CMT N/A
  • SGMT N/A
  • EPS Growth
  • CMT N/A
  • SGMT N/A
  • EPS
  • CMT 1.75
  • SGMT N/A
  • Revenue
  • CMT $313,657,000.00
  • SGMT N/A
  • Revenue This Year
  • CMT N/A
  • SGMT N/A
  • Revenue Next Year
  • CMT N/A
  • SGMT N/A
  • P/E Ratio
  • CMT $7.60
  • SGMT N/A
  • Revenue Growth
  • CMT N/A
  • SGMT N/A
  • 52 Week Low
  • CMT $13.00
  • SGMT $2.39
  • 52 Week High
  • CMT $21.00
  • SGMT $7.64
  • Technical
  • Relative Strength Index (RSI)
  • CMT 35.93
  • SGMT 43.11
  • Support Level
  • CMT $13.00
  • SGMT $3.96
  • Resistance Level
  • CMT $14.22
  • SGMT $4.83
  • Average True Range (ATR)
  • CMT 0.47
  • SGMT 0.38
  • MACD
  • CMT 0.00
  • SGMT -0.04
  • Stochastic Oscillator
  • CMT 15.76
  • SGMT 13.39

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Share on Social Networks: